Indkaldelse til ordinær generalforsamling i Genmab A/S
March 03, 2015 01:37 ET
|
Genmab A/S
Selskabsmeddelelse
Genmab A/S afholder generalforsamling den 26. marts 2015
København, Danmark, 3. marts 2015 – Genmab A/S (OMX: GEN) afholder ordinær generalforsamling torsdag den 26. marts...
Genmab 2014 Annual Report
March 02, 2015 11:03 ET
|
Genmab A/S
Copenhagen, Denmark; March 2, 2015 – Genmab A/S (OMX: GEN) announced today its Annual Report for 2014. Below is a summary from the report of business progress and financial performance for the year,...
Genmab 2014 Annual Report
March 02, 2015 11:03 ET
|
Genmab A/S
Copenhagen, Denmark; March 2, 2015 – Genmab A/S (OMX: GEN) announced today its Annual Report for 2014. Below is a summary from the report of business progress and financial performance for the...
Genmab Announces That Agreement to Transfer Ofatumumab Collaboration to Novartis is Now Effective
March 02, 2015 01:26 ET
|
Genmab A/S
Company Announcement
Agreement to transfer ofatumumab collaboration from GSK to Novartis is now effective
Genmab will not be required to pay existing funding liabilities or have any future...
Genmab meddeler, at aftalen om overdragelse af ofatumumab-samarbejdet til Novartis er trådt i kraft
March 02, 2015 01:26 ET
|
Genmab A/S
Selskabsmeddelelse
Aftalen om overdragelse af ofatumumab-samarbejdet fra GSK til Novartis er nu endelig
Genmab vil ikke skulle betale eksisterende finansieringsforpligtelser eller have...
Genmab indgår kommerciel aftale om DuoBody teknologien med BioNovion inden for immuno-onkologi området
February 19, 2015 09:26 ET
|
Genmab A/S
Selskabsmeddelelse
Aftale om fælles udvikling med BioNovion
Bispecifikke antistoffer rettet mod immuno-onkologi targets vil blive skabt med DuoBody teknologien
København, Danmark; 19....
Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology
February 19, 2015 09:26 ET
|
Genmab A/S
Company Announcement
Co-development agreement with BioNovion
Bispecific antibodies to immuno-oncology targets to be created with DuoBody Technology
Copenhagen, Denmark; February 19,...
Major Shareholder Announcement
February 04, 2015 17:42 ET
|
Genmab A/S
Company Announcement
Major shareholder announcement for Genmab A/S
Copenhagen, Denmark; February 4, 2015 – Genmab A/S (OMX: GEN) announces under reference to Section 29 of the Danish...
Storaktionærmeddelelse for Genmab A/S
February 04, 2015 17:42 ET
|
Genmab A/S
Selskabsmeddelelse
Storaktionærmeddelelse for Genmab A/S
København, Danmark, 4. februar 2015 – Genmab A/S (OMX: GEN) skal under henvisning til Værdipapirhandelslovens § 29 meddele, at...
Fourth Quarter and Full Year 2014 Net Sales Figures for Arzerra (ofatumumab)
February 04, 2015 07:01 ET
|
Genmab A/S
Company Announcement
Worldwide net sales of Arzerra™ in Q4 2014 totaled GBP 12.3 million
Full year 2014 net sales of Arzerra were GBP 54.5 million
Genmab royalty income is DKK 23...